A Randomized, Open-Label, Phase II Study Comparing Pemetrexed Plus Cisplatin Followed by Maintenance Pemetrexed versus Pemetrexed Alone in Patients with Epidermal Growth Factor Receptor (EGFR)-Mutant Non-small Cell Lung Cancer after Failure of First-Line EGFR Tyrosine Kinase Inhibitor: KCSG-LU12-13
一项随机、开放标签的 II 期研究，比较培美曲塞联合顺铂序贯培美曲塞维持治疗与单用培美曲塞治疗一线 EGFR 酪氨酸激酶抑制剂治疗失败的表皮生长因子受体 (EGFR) 突变型非小细胞肺癌患者的疗效：KCSG-LU12-13
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2018.324
Yoo, Kwai Han; Lee, Su Jin; Cho, Jinhyun; Lee, Ki Hyeong; Park, Keon Uk; Kim, Ki Hwan; Cho, Eun Kyung; Choi, Yoon Hee; Kim, Hye Ryun; Kim, Hoon-Gu; Ahn, Heui June; Lee, Ha Yeon; Yun, Hwan Jung; Kang, Jin-Hyoung; Jeong, Jaeheon; Choi, Moon Young; Jung, Sin-Ho; Sun, Jong-Mu; Lee, Se-Hoon; Ahn, Jin Seok; Park, Keunchil; Ahn, Myung-Ju
